Abstract
Asthma is one of the most costly chronic illnesses in both the developed and developing world. Asthma is a significant factor in the use of health care services, particularly emergency departments and prescription medications. In the United States, asthma is the 13th most costly medical condition and the 7th leading cause of work-loss days (Druss et al. 2002). The cost for patients with asthma in Western countries ranges from $300 to $1,300 per capita per year (Braman 2006). In the future, costs are expected to substantially increase. The purpose of this chapter is to discuss the cost of asthma to society and to evaluate the role of cost in individual access to care. The impact of cost on societies differs from that on individuals. For societies, the economic burden of an illness can help to prioritize the use of economic resources. Understanding which illnesses, from a societal perspective, use the most resources can suggest illnesses where treatments can be potentially cost saving.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Accordini S, Bugiani M, Arossa W, Gerzeli S, Marinoni A, Olivieri M, Pirina P, Carrozzi L, Dallari R, De Togni A, de Marco R (2006) Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol 141(2):189–198
Anonymous (2002) Diverse approaches to asthma DM succeed in Medicaid populations. Dis Manag Advis 8(5):71–77
Antonicelli L, Bucca C, Neri M, De Benedetto F, Sabbatani P, Bonifazi F, Eichler HG, Zhang Q, Yin DD (2004) Asthma severity and medical resource utilisation. Eur Respir J 23(5):723–729
Arnlind MH, Nokela M, Rehnberg C, Jonsson EW (2006) The relationship between pharmaceutical costs, disease severity, and health-related quality of life in asthmatics in Swedish primary care. J Asthma 43(8):585–591
Ather S, Chung KD, Gregory P, Demissie K (2004) The association between hospital readmission and insurance provider among adults with asthma. J Asthma 41(7):709–713
Bender BG, Rand C (2004) Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol 4(3):191–195
Birnbaum H, Berger W, Greenberg P, Holland M, Auerbach R, Atkins K, Wanke L (2002) Direct and indirect costs of asthma to an employer. J Allergy Clin Immunol 109(2):264–270
Blais L, Beauchesne MF, Levesque S (2006) Socioeconomic status and medication prescription patterns in pediatric asthma in Canada. J Adolesc Health 38(5):607.e9–607.e16
Blanc PD, Trupin L, Eisner M, Earnest G, Katz PP, Israel L, Yelin EH (2001) The work impact of asthma and rhinitis: findings from a population-based survey. J Clin Epidemiol 54(6):610–618
Bloom B, Bruno D, Maman D, Jayadevappa R (2001) Usefulness of US cost-of-illness studies in healthcare decision making. Pharmacoeconomics 19(2):207–213
Braman SS (2006) The global burden of asthma. Chest 130(1):4S–12S
Castro M, Zimmermann NA, Crocker S, Bradley J, Leven C, Schechtman KB (2003) Asthma intervention program prevents readmissions in high healthcare users. Am J Respir Crit Care Med 168(9):1095–1099
Celik GE, Bavbek S, Paaolu G, Mungan D, Abadolu O, Harmanci E, Misirligil Z (2004) Direct medical cost of asthma in Ankara, Turkey. Respiration 71(6):587–593
Chernew M, Rosen A, Fendrick AM (2007) Value-based insurance design. Health Aff 26(2):w195–w203
Chew FT, Goh DY, Lee BW (1999) The economic cost of asthma in Singapore. Aust N Z J Med 29(2):228–233
Cisternas MG, Blanc PD, Yen IH, Katz PP, Earnest G, Eisner MD, Shiboski S, Yelin EH (2003) A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol 111(6):1212–1218
Colice G, Wu E, Birnbaum H, Daher M, Marynchenko M, Varghese S (2006) Healthcare and workloss costs associated with patients with persistent asthma in a privately insured population. J Occup Environ Med 48(8):794–802
Crown WH, Berndt ER, Baser O, Finkelstein SN, Witt WP, Maguire J, Haver KE (2004) Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter? Front Health Policy Res 7:95–127
Dasgupta R, Guest JF (2003) Factors affecting UK primary-care costs of managing patients with asthma over 5 years. Pharmacoeconomics 21(5):357–369
David C (2004) Preventive therapy for asthmatic children under Florida Medicaid: changes during the 1990s. J Asthma 41(6):655–661
Drummond M (1992) Cost of illness studies: a major headache? Pharmacoeconomics 2(1):1–4
Druss B, Marcus SC, Olfson M, Pincus A (2002) The most expensive medical conditions in America. Health Aff 21(4):105–111
Eisenberg SS (2004) Building the case for asthma as a disease management program. Dis Manag 7(3):202–215
Ferris TG, Blumenthal D, Woodruff PG, Clark S, Camargo CA, MARC Investigators (2002) Insurance and quality of care for adults with acute asthma. J Gen Intern Med 17(12):905–913
Fox HB, McManus MA, Reichman MB (2003) Private health insurance for adolescents: is it adequate? J Adolesc Health 32(6 Suppl):12–24
Fredrickson DD, Molgaard CA, Dismuke SE, Schukman JS, Walling A (2004) Understanding frequent emergency room use by Medicaid-insured children with asthma: a combined quantitative and qualitative study. J Am Board Fam Pract 17(2):96–100
Freeman NC, Schneider D, McGarvey P (2003) The relationship of health insurance to the diagnosis and management of asthma and respiratory problems in children in a predominantly Hispanic urban community. Am J Public Health 93(8):1316–1320
Gold M, Siegel J, Russell L, Weinstein M (1996) Cost-effectiveness in health and medicine. Oxford University Press, Oxford
Grupp-Phelan J, Lozano P, Fishman P (2001) Health care utilization and cost in children with asthma and selected comorbidities. J Asthma 38(4):363–373
Herjavecz I, Nagy GB, Gyurkovits K, Magyar P, Dobos K, Nagy L, Alemao E, Ben-Joseph R (2003) Cost, morbidity, and control of asthma in Hungary: The Hunair Study. J Asthma 40(6):673–681
Hodgson T (1994) Cost of illness in cost-effectiveness analysis: a review of the methodology. Pharmacoeconomics 6(6):536–552
Joshi AV, Madhavan SS, Ambegaonkar A, Smith M, Scott VG, Dedhia H (2006) Association of medication adherence with workplace productivity and health-related quality of life in patients with asthma. J Asthma 43(7):521–526
Jowers JR, Schwartz AL, Tinkelman DG, Reed KE, Corsello PR, Mazzei AA, Bender DR, Lochhead RA (2000) Disease management program improves asthma outcomes. Am J Manag Care 6(5):585–592
Kiivet RA, Kaur I, Lang A, Aaviksoo A, Nirk L (2001) Costs of asthma treatment in Estonia. Eur J Public Health 11(1):89–92
Koopmanschap M (1998) Cost of illness studies. Useful for health policy? Pharmacoeconomics 14(2):143–148
Krahn MD, Berka C, Langlois P, Detsky AS (1996) Direct and indirect costs of asthma in Canada, 1990. CMAJ 154(6):821–831
Lodha R, Puranik M, Kattal N, Kabra SK (2003) Social and economic impact of childhood asthma. Indian Pediatr 40(9):874–879
Lozano P, Fishman P, VonKorff M, Ad Hecht J (1997) Health care utilization and cost among children with asthma who were enrolled in a health maintenance organization. Pediatrics 99(6):757–764
Lozano P, Sullivan SD, Smith DH, Weiss KB (1999) The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol 104(5):957–963
Malone DC, Lawson KA, Smith DH (2000) Asthma: an analysis of high-cost patients. Pharm Pract Manag Q 20(1):12–20
Markovitz BP, Andresen EM (2006) Lack of insurance coverage and urgent care use for asthma: a retrospective cohort study. BMC Public Health 6:14
McConnochie KM, Russo MJ, McBride JT, Szilagyi PG, Brooks AM, Roghmann KJ (1999) Socioeconomic variation in asthma hospitalization: excess utilization or greater need? Pediatrics 103(6):e75
Meng YY, Babey SH, Brown ER, Malcolm E, Chawla N, Lim YW (2006) Emergency department visits for asthma: the role of frequent symptoms and delay in care. Ann Allergy Asthma Immunol 96(2):291–297
Milton B, Whitehead M, Holland P, Hamilton V (2004) The social and economic consequences of childhood asthma across the lifecourse: a systematic review. Child Care Health Dev 30(6):711–728
Navarro RP, Parasuraman B (2005) Cost effectiveness of asthma controller therapies: influence of disease severity and other variables. Manag Care Interface 18(6):31–40
Ortega AN, Belanger KD, Paltiel AD, Horwitz SM, Bracken MB, Leaderer BP (2001) Use of health services by insurance status among children with asthma. Med Care 39(10):1065–1074
Piecoro LT, Potoski M, Talbert JC, Doherty DE (2001) Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population. Health Serv Res 36(2):357–371
Rossiter LF, Whitehurst-Cook MY, Small RE, Shasky C, Bovbjerg VE, Penberthy L, Okasha A, Green J, Ibrahim IA, Yang S, Lee K (2000) The impact of disease management on outcomes and cost of care: a study of low-income asthma patients. Inquiry 37(2):188–202
Rutten van-Molken MP, Feenstra TL (2001) The burden of asthma and chronic obstructive pulmonary disease: data from The Netherlands. Pharmacoeconomics 19(Suppl 2):1–6
Rutten-van Molken MP, Postma MJ, Joore MA, Van Genugten ML, Leidl R, Jager JC (1999) Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands. Respir Med 93(11):779–787
Schwenkglenks M, Lowy A, Anderhub H, Szucs TD (2003) Costs of asthma in a cohort of Swiss adults: associations with exacerbation status and severity. Value Health 6(1):75–83
Sennhauser FH, Braun-Fahrlander C, Wildhaber JH (2005) The burden of asthma in children: a European perspective. Paediatr Respir Rev 6(1):2–7
Serra-Batlles J, Plaza V, Morejon E, Comella A, Brugues J (1998) Costs of asthma according to the degree of severity. Eur Respir J 12(6):1322–1326
Shiell A, Gerard K, Donaldson C (1987) Cost of illness studies: an aid to decision-making? Health Policy 8:317–323
Sin DD, Svenson LW, Cowie RL, Man SF (2003) Can universal access to health care eliminate health inequities between children of poor and nonpoor families?: a case study of childhood asthma in Alberta. Chest 124(1):51–56
Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB (1997) A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 156(3):787–793
Stempel DA, Spahn JD, Stanford RH, Rosenzweig JR, McLaughlin TP (2006) The economic impact of children dispensed asthma medications without an asthma diagnosis. J Pediatr 148(6):819–823
Stevens CA, Turner D, Kuehni CE, Couriel JM, Silverman M (2003) The economic impact of preschool asthma and wheeze. Eur Respir J 21(6):1000–1006
Stock S, Redaelli M, Luengen M, Wendland G, Civello D, Lauterbach KW (2005) Asthma: prevalence and cost of illness. Eur Respir J 25(1):47–53
Szucs T, Anderhub H, Rutishauser M (1999) The economic burden of asthma: direct and indirect costs in Switzerland. Eur Respir J 13:281–286
Szucs TD, Anderhub HP, Rutishauser M (2000) Determinants of health care costs and patterns of care of asthmatic patients in Switzerland. Schweiz Med Wochenschr 130(9):305–313
Tinkelman D, Wilson S (2004) Asthma disease management: regression to the mean or better? Am J Manag Care 10(12):948–954
Ungar WJ, Coyte PC (2000) Measuring productivity loss days in asthma patients. The Pharmacy Medication Monitoring Program and Advisory Board. Health Econ 9(1):37–46
Van Ganse E, Laforest L, Pietri G, Boissel JP, Gormand F, Ben-Joseph R, Ernst P (2002) Persistent asthma: disease control, resource utilisation and direct costs. Eur Respir J 20(2):260–267
Van Ganse E, Antonicelli L, Zhang Q, Laforest L, Yin DD, Nocea G, Sazonov Kocevar V (2006) Asthma-related resource use and cost by GINA classification of severity in three European countries. Respir Med 100(1):140–147
Wang LY, Zhong Y, Wheeler L (2005) Direct and indirect costs of asthma in school-age children. Prev Chronic Dis 2(1):A11
Weiss KB, Gergen PJ, Hodgson TA (1992) An economic-evaluation of asthma in the United-States. N Engl J Med 326(13):862–866
Weiss KB, Sullivan SD, Lyttle CS (2000) Trends in the cost of illness for asthma in the United States, 1985–1994. J Allergy Clin Immunol 106(3):493–499
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Atherly, A. (2010). The Cost of Asthma. In: Harver, A., Kotses, H. (eds) Asthma, Health and Society. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-78285-0_19
Download citation
DOI: https://doi.org/10.1007/978-0-387-78285-0_19
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-78284-3
Online ISBN: 978-0-387-78285-0
eBook Packages: MedicineMedicine (R0)